Rei7.0

Reishi

Ganoderma lucidum (Lingzhi)

The 'mushroom of immortality' used for centuries to support immune function, sleep quality, and stress resilience.

immunesleepmentalmushroomadaptogenimmunesleep
Last reviewed: January 1, 2025
7.0/10
40+ studies
Evidence
moderate
Safety
1-3g dried mushroom or 500-1500mg extract
Dose
4-8 weeks
Time to Effect
Dual-extract (water + alcohol) capsules or powder
Best Form

Reishi is a medicinal mushroom with over 2,000 years of use in Asian medicine. Known as the 'mushroom of immortality,' it contains beta-glucans and triterpenes that support immune function. Unlike stimulating adaptogens, reishi has calming properties that support sleep and stress resilience. Often used for immune support and general wellness.

Mechanisms of Action

πŸ›‘οΈ
Immune Modulation

Activates and balances immune function

βš–οΈ
Adaptogenic/Calming

Supports stress resilience with calming effects

Recommended Dose

1-3g dried mushroom or 500-1500mg extract

500mg3000mg

Optimal Timing

  • Evening (for sleep)
  • With or without food

Can be taken without food

Best Form

Dual-extract (water + alcohol) capsules or powder

Alternatives: Hot water extract, Spore powder

Dual extraction captures both water-soluble beta-glucans and alcohol-soluble triterpenes. Look for fruiting body extracts.

Duration

Minimum: 4 weeks

Optimal: 8 weeks

Cycling: Not required

Note: Calming effects make evening dosing ideal. Can be taken any time for immune support.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

πŸ›‘οΈ
Immune Support

Enhanced immune function

4-8 weeks
60% of users notice thispositive
😴
Better Sleep

Improved sleep quality and calmness

2-4 weeks
55% of users notice thispositive
😌
Stress Resilience

Better stress adaptation

4-8 weeks
50% of users notice thispositive
ModerateMax safe dose: Up to 3g dried equivalent/day typically used
πŸ”΄
Pregnant/nursing

Insufficient data; avoid

🟑
Autoimmune conditions

Use with caution β€” may stimulate immune system

Who Should NOT Take This

  • Bleeding disorders
  • Before surgery
  • Autoimmune conditions (use with caution)

Drug Interactions

Blood thinnersmoderate

May increase bleeding risk

Immunosuppressantsmoderate

May counteract immunosuppressive effects

Blood pressure medicationsmild

May have additive blood pressure lowering

mycophenolatemajor

Possible reduced effectiveness, rejection risk

Possible Side Effects

GI upsetuncommon

Tip: Take with food

Dizzinessrare

Tip: Reduce dose

Dry mouth/throatuncommon

Tip: Stay hydrated

Warnings

  • May affect blood clotting β€” stop before surgery
  • Quality varies greatly β€” choose reputable brands
  • Rare liver toxicity reported with some products

Top studies from 40+ peer-reviewed papers

systematic-reviewn=469
DOI

Weiner JD et al. β€’ Lupus science & medicine (2025)

β€œWe identified 227 herbal supplements with immunostimulatory properties, of which 15 were most strongly supported by the evidence.”
Key Findings:
  • We identified 227 herbal supplements with immunostimulatory properties, of which 15 were most strongly supported by the evidence.
  • This article may serve as a reference to help clinicians counsel patients with autoimmune skin diseases on the risks associated with use of specific herbal supplements.
  • Further research warranted to confirm findings
systematic-review
DOI

Ahmad R et al. β€’ Phytotherapy research : PTR (2021)

β€œYet, a gap in research exists for Reishi, which is discussed in detail in the forthcoming sections.Β© 2021 John Wiley & Sons Ltd.”
Key Findings:
  • In particular, quality clinical data are intensely needed to support pharmacological activities for human use.
  • Reishi possesses many valuable pharmacological activities, and the number of patents and clinical trials is increasing for Reishi.
  • Yet, a gap in research exists for Reishi, which is discussed in detail in the forthcoming sections.Β© 2021 John Wiley & Sons Ltd.
meta-analysis
DOI

GonzΓ‘lez A et al. β€’ Nutrients (2020)

β€œEx vivo studies conducted in human blood cells show the radioprotective effect of Ξ²-glucan of aqueous extract of G. lucidum, nevertheless, its implementation as radioprotector to humans is in need of further clinical research studies.”
Key Findings:
  • From a total number of 1109 records identified, 15 full text articles were eligible, none of them were clinical trials.
  • In vivo studies reveal the efficiency of G. lucidum aqueous extracts of polysaccharides and triterpenes in mice exposed to Ξ³-rays.
  • In plasmid, they can reduce radiation damage as an increment of the open circular form, as well as increase the DNA extension, as shown in vitro studies.
  • Ex vivo studies conducted in human blood cells show the radioprotective effect of Ξ²-glucan of aqueous extract of G. lucidum, nevertheless, its implementation as radioprotector to humans is in need of further clinical research studies.
systematic-review
DOI

Zhang Y et al. β€’ Progress in molecular biology and translational science (2019)

β€œAll rights reserved.”
Key Findings:
  • In this study, we will review the biological activities and preclinical studies of GSP in China based on literatures searches from CNKI (China National Knowledge Infrastructure), VIP (Chongqing VIP Chinese Scientific Journals Database), Wanfang database, and PubMed database.
  • Both basic and preclinical studies showed that GSP has antitumor, antioxidant, anticytopenia, and unique mushroom-poison detoxification properties that are different from that of GLPS.
  • Our goal is to provide a molecular picture that would allow in-depth evaluation of GSP as one of few glycan-based drugs that has been used as an immunomodulatory adjunctive drug during cancer therapy.Β© 2019 Elsevier Inc.
  • All rights reserved.
meta-analysisn=398
DOI

Klupp NL et al. β€’ The Cochrane database of systematic reviews (2015)

β€œEvidence from a small number of randomised controlled trials does not support the use of G lucidum for treatment of cardiovascular risk factors in people with type 2 diabetes mellitus.”
Key Findings:
  • We found no improvement for fasting plasma glucose (WMD 0.30 mmol/L; 95% CI -0.95 mmol/L to 1.55 mmol/L).
  • There were no statistically significant differences between groups for blood pressure or triglycerides.
  • Participants who took G lucidum for four months were 1.67 times (RR 1.67 95% CI 0.86 to 3.24) more likely to experience an adverse event than those who took placebo but these were not serious side effects.
40
Total Studies
8.9/10
Avg Quality
14-469
Sample Size Range
2005-2025
Research Span

Study Type Distribution

Systematic Review
26
RCT
9
Meta-Analysis
3
Crossover
1
Observational
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.